Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Proton MRI Breast Cancer Imaging May Reduce False-Positives Findings

By HospiMedica International staff writers
Posted on 15 Oct 2013
A collaboration of scientists is developing a new breast cancer screening technique that has the potential to reduce false-positives, and thereby potentially lessen the need for invasive biopsies.

Led by Brigham Young University (BYU; Salt Lake City, UT, USA) electrical engineer Dr. More...
Neal Bangerter and University of Utah (Salt Lake City, UT, USA) collaborators Drs. Rock Hadley and Joshua Kaggie, the group has created a magnetic resonance imaging (MRI) device that could improve both the process and accuracy of breast cancer screening by scanning for sodium levels in the breast. “The images we’re obtaining show a substantial improvement over anything that we’ve seen using this particular MRI technique for breast cancer imaging,” said Dr. Bangerter, senior author on a study published online September 16, 2013, in the journal Magnetic Resonance in Medicine.

To be specific, the device is generating as much as five-times more accurate images than earlier efforts with a newly developed methodology called sodium MRI. There are two clinical imaging technique currently widely used for screening breast cancer: mammograms and proton MRI scans.

Mammography is the most widely used screening approach, but the procedure involves X-ray exposure and is typically unpleasant. Mammograms are comparatively inexpensive, but they still lead to biopsies when something suspicious is detected. Because of their increased sensitivity, proton MRI scans are typically used to additionally study suspicious areas identified by mammography. However, they can generate false-positives that can lead to unnecessary interventions.

Sodium MRI has the potential to improve evaluation of breast lesions because sodium concentrations are believed to increase in malignant tumors. Dr. Bangerter and his coworkers believe that the addition of sodium MRI to breast cancer screening could provide important additional diagnostic data that will decrease the chances for false-positive findings.

The investigators have developed a new device used for sodium imaging that is capturing a degree of detail and structure never before achieved. “This development by Dr. Bangerter and his group represents a major advance in the field of multinuclear MRI of the breast,” said Stanford professor of radiology Bruce Daniel. “He and his group have invented a way to dramatically boost the sodium signal from the breast, enabling much better, higher resolution sodium MR images to be obtained. This should open the door to new avenues of research into breast cancer.”

The innovative method produces, so far, high-quality images in only 20 minutes, improving the chanced that sodium MRI breast scans could be implemented clinically. The MRI team’s objective is to produce a device capable of obtaining both excellent sodium and good proton images without requiring the patient being screened to be repositioned for multiple scans. “This method is giving us new physiological information we can’t see from other types of images,” Dr. Bangerter said. “We believe this can aid in early breast cancer detection and characterization while also improving cancer treatment and monitoring.”

Related Links:

Brigham Young University
University of Utah



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.